Skip to main content

Table 3 Cost-effectiveness Ratio per DALYs averted all referencing common baseline

From: A cost-effectiveness analysis of COVID-19 critical care interventions in Addis Ababa, Ethiopia: a modeling study

Cost, effectiveness, average and incremental cost-effectiveness ratio per DALYs averted

Strategy

Cost (USD)

Incremental cost

Eff (DALYs)

Incremental Eff

ACER

ICER

Noninvasive

6990.143

Ā 

3.511

Ā 

1991

Ā 

Invasive

10,887.619

3897.476

2.723

0.788

3998

4948

  1. USD United States dollar, DALYs Disability adjusted life years, Eff Effectiveness